作者: Yolanda S. Kap , Paul Smith , S. Anwar Jagessar , Ed Remarque , Erwin Blezer
DOI: 10.4049/JIMMUNOL.180.3.1326
关键词: Immunology 、 Encephalomyelitis 、 Biology 、 Experimental autoimmune encephalomyelitis 、 Myelin oligodendrocyte glycoprotein 、 CD8 、 Cytotoxic T cell 、 Myelin 、 T cell 、 Oligodendrocyte
摘要: The recombinant human (rh) myelin/oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE) model in the common marmoset is characterized by 100% disease incidence, a chronic course, and variable time interval between immunization neurological impairment. We investigated whether monkeys with fast slow progression display different anti-MOG T or B cell responses analyzed underlying pathogenic mechanism(s). results show that progressor significantly wider specificity diversification of cells at necropsy than progressors, especially against MOG(34-56) MOG(74-96). emerged as critical encephalitogenic peptide, inducing severe multiple lesions inflammation, demyelination, axonal injury CNS. Although EAE was not observed MOG(74-96)-immunized monkeys, weak low grade CNS pathology were detected. When these cases received booster IFA, full-blown developed. MOG(34-56)-reactive expressed CD3, CD4, CD8 CD56, but CD16. Moreover, MOG(34-56)-specific lines displayed specific cytotoxic activity peptide-pulsed lines. phenotype suggest are NK-CTL. These support concept may play role pathogenesis sclerosis.